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Abstract 
Background: The descending antinociceptive system (DAS) is thought to play crucial roles in the antinociceptive 
effect of spinal cord stimulation (SCS), especially through its serotonergic pathway. The nucleus raphe magnus (NRM) 
in the rostral ventromedial medulla is a major source of serotonin [5-hydroxytryptamine (5-HT)] to the DAS, but the 
role of the dorsal raphe nucleus (DRN) in the ventral periaqueductal gray matter is still unclear. Moreover, the influ-
ence of the noradrenergic pathway is largely unknown. In this study, we evaluated the involvement of these sero-
tonergic and noradrenergic pathways in SCS-induced antinociception by behavioral analysis of spinal nerve-ligated 
(SNL) rats. We also investigated immunohistochemical changes in the DRN and locus coeruleus (LC), regarded as the 
adrenergic center of the DAS, and expression changes of synthetic enzymes of 5-HT [tryptophan hydroxylase (TPH)] 
and norepinephrine [dopamine β-hydroxylase (DβH)] in the spinal dorsal horn.
Results: Intrathecally administered methysergide, a 5-HT1- and 5-HT2-receptor antagonist, and idazoxan, an α2-
adrenergic receptor antagonist, equally abolished the antinociceptive effect of SCS. The numbers of TPH-positive sero-
tonergic and phosphorylated cyclic AMP response element binding protein (pCREB)-positive neurons and percentage 
of pCREB-positive serotonergic neurons in the DRN significantly increased after 3-h SCS. Further, the ipsilateral-to-
contralateral immunoreactivity ratio of DβH increased in the LC of SNL rats and reached the level seen in naïve rats, 
even though the number of pCREB-positive neurons in the LC was unchanged by SNL and SCS. Moreover, 3-h SCS did 
not increase the expression levels of TPH and DβH in the spinal dorsal horn.
Conclusions: The serotonergic and noradrenergic pathways of the DAS are involved in the antinociceptive effect of 
SCS, but activation of the DRN might primarily be responsible for this effect, and the LC may have a smaller contribu-
tion. SCS does not potentiate the synthetic enzymes of 5HT and norepinephrine in the neuropathic spinal cord.
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Background
Spinal cord stimulation (SCS) is widely performed to 
manage intractable pain. The antinociceptive effect 
of serotonin (5-HT) in the spinal cord is well docu-
mented in animals [1–4]. Intrathecal 5-HT admin-
istration facilitates SCS-induced antinociception 
[5]. Early studies revealed that electrical stimula-
tion of the brain stem, dorsolateral funiculus, and 
peripheral nerves activates the serotonergic path-
way of the descending antinociceptive system (DAS), 
with 5-HT release in the spinal cord resulting in an 
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antinociceptive response [6, 7]. Moreover, electrical 
stimulation at the level of the dorsal column nuclei 
attenuates the flexor reflex and hypersensitivity after 
peripheral nerve injury [8, 9]. Therefore, the antino-
ciceptive effect of SCS might involve supraspinal 
neural circuits via activation of the DAS, which is at 
least partly serotonergic. The nucleus raphe magnus 
(NRM) in the rostral ventromedial medulla (RVM) is 
a major serotonergic center in the brain stem, and its 
stimulation induces GABA release into the spinal dor-
sal horn [10] and antinociception [11, 12]. However, 
the role of the dorsal raphe nucleus (DRN), a source of 
5-HT in the ventral periaqueductal gray matter (PAG), 
still needs to be elucidated.
The noradrenergic pathway of the DAS is activated 
in animal models of neuropathic pain [13, 14], and α2-
adrenergic agonists have antinociceptive effects in both 
animals and patients with neuropathic pain [15–20]. In 
addition, clonidine, an α2-adrenergic agonist, potentiates 
the analgesic effect of SCS after tactile hypersensitivity in 
animal models of neuropathic pain [13, 21–24]. However, 
the contribution of the noradrenergic pathway to SCS-
induced antinociception is controversial.
It has been believed that 5-HT and noradrenaline in 
spinal dorsal horn would be synthesized in the supraspi-
nal center of the serotonergic and noradrenergic nuclei 
respectively, and transported to the spinal cord. On the 
other hand, 5-HT [tryptophan hydroxylase (TPH)] and 
norepinephrine [dopamine β-hydroxylase (DβH)] syn-
thetic enzymes are expressed in the spinal cord, so the 
corresponding neurotransmitters could be synthesized 
locally. However, we had little information on how spi-
nal 5-HT and norepinephrine production contributes 
to SCS-induced antinociception, despite several studies 
suggesting that these neurotransmitters would be pro-
duced in the serotonergic and noradrenergic neurons in 
brain stem nuclei [25, 26]. Moreover, it is still unclear 
whether spinal or supraspinal modulation is essential 
for SCS-induced antinociception, despite recent studies 
showing that segmental effects in the spinal cord are cru-
cial for antinociception by SCS [27, 28].
To answer these questions, we investigated whether the 
serotonergic and noradrenergic pathways of the DAS are 
involved in the antinociceptive effect of SCS by behavio-
ral analyses of spinal nerve-ligated (SNL) rats. To identify 
the essential supraspinal centers, we performed immuno-
histochemical analyses of tissues containing the DRN and 
locus coeruleus (LC), regarded as the adrenergic center 
of the DAS. Finally, to elucidate whether local synthesis 
of the neurotransmitters is important for SCS-induced 
antinociception, we evaluated changes in the expression 
of TPH and DβH in the spinal dorsal horn with or with-
out SCS by western blot analyses.
Results
Methysergide and idazoxan attenuated the antinociceptive 
effect of SCS
Spinal nerve-ligated (SNL) rats showed ipsilateral 
mechanical hypersensitivity. SCS significantly reduced 
the hypersensitivity in about 70% of these rats (baseline 
paw withdrawal threshold [PWT] =  21.4 ±  2.3  g; after 
1-h SCS = 30.9 ± 2.4 g; after 2-h SCS = 29.6 ± 2.4 g; after 
3-h SCS = 30.2 ± 3.2 g; F [3, 32] = 3.78; p = 0.02). It how-
ever did not significantly affect contralateral PWT (base-
line =  37.5 ±  3.4 g; after 1-h SCS =  40.9 ±  3.1 g; after 
2-h SCS = 38.5 ± 3.4 g; after 3-h SCS = 41.5 ± 2.1 g; F 
[3, 32]  =  0.43; p  =  0.73). Significant differences in the 
antinociceptive effect were noted between the ipsilateral 
and the contralateral hind paws (baseline PWT differ-
ence, p = 0.0044; stimulated PWT difference, p < 0.001; 
interaction of side and treatment, p  =  0.022; n  =  9) 
(Figure 1b).
Intrathecally administered methysergide and idazoxan 
significantly attenuated the antinociceptive effect of 
SCS for at least 2 h in the ipsilateral hind paw [(baseline 
PWT = 15.5 ± 1.3 g; after 1-h SCS = 31.3 ± 4.3 g; 1 and 
2 h after methysergide administration = 19.1 ± 1.1 and 
23.4 ±  1.7  g, respectively; F [3, 20] =  9.33; p =  0.0005; 
Figure 1c) and (baseline PWT = 20.3 ± 2.4 g; after 1-h 
SCS =  30.8 ±  2.6  g; 1 and 2  h after idazoxan adminis-
tration = 22.6 ± 2.6 and 22.5 ± 2.4 g, respectively; F [3, 
24]  =  3.43; p  =  0.033; Figure  1d)]. However, they did 
not affect contralateral PWT [(methysergide: baseline 
PWT difference, p  <  0.001; stimulated PWT difference, 
p = 0.0014; interaction of side and treatment, p < 0.001; 
n = 6) and (baseline PWT difference, p = 0.011; stimu-
lated PWT difference, p = 0.0013; interaction of side and 
treatment, p = 0.078; n = 7)]. Furthermore, neither drug 
potentiated hyperalgesia in the ipsilateral or contralateral 
hind paws at the dose given (30 μg) (Figure 2b, c).
SCS activated serotonergic neurons in the DRN
Spinal nerve-ligated itself did not affect the numbers of 
TPH-positive and pCREB-positive serotonergic neu-
rons in the DRN. However, their numbers were signifi-
cantly increased in 3-h stimulated rats compared with 
naïve and SNL rats [(TPH-positive serotonergic neu-
rons: naïve, 196.1 ± 20.4; SNL, 146.6 ± 17.6; SNL + SCS, 
317.9 ± 28.1; F [2, 31] = 17.1; p < 0.0001) and (pCREB-
positive serotonergic neurons: naïve, 503.7 ± 79.7; SNL, 
451.5 ± 63.2; SNL + SCS, 702.3 ± 51.2; F [2, 31] = 4.21; 
p < 0.05; Figure 2j)]. Moreover, the percentage of pCREB-
positive serotonergic neurons was significantly increased 
in stimulated rats compared to that in the positive con-
trols (naïve, 77.9 ± 2.7%; SNL, 71.2 ± 4.1%; SNL + SCS, 
88.9  ±  2.4%; F [2, 24]  =  8.71; p  <  0.001 for SNL vs. 
SNL+SCS; Figure 2k).
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SCS did not activate noradrenergic neurons in the LC 
but reversed upregulated DβH expression  
on the ipsilateral side
The numbers of pCREB-positive nuclei (per 10,000 µm2) 
in the ipsilateral and contralateral sides of the LC were 
not significantly different among the groups (naïve: 
contralateral, 19.8  ±  2.0; ipsilateral, 17.0  ±  2.0; SNL: 
contralateral, 19.1  ±  2.0; ipsilateral side, 20.3  ±  1.4; 
SNL  +  SCS: contralateral, 19.9  ±  1.4; ipsilateral, 







































































with or without SCS (50Hz, 0.2ms) 
Figure 1 Assessment of mechanical hypersensitivity and antianalgesic effect of 5-HT and α2-adrenergic receptor antagonists. a Time course of the 
behavioral experiment. PWT was measured by an automated von Frey device five times on each side. After the baseline measurement, SCS (0.2 ms, 
50 Hz, 70–80% of the motor threshold) was initiated and PWT was assessed every hour. Methysergide (5-HT receptor antagonist; 30 μg), idazoxan 
(α2-adrenergic receptor antagonist; 30 μg), or saline was administered as a bolus via intrathecal catheters in freely moving rats immediately after 
verifying the antinociceptive effect of 1-h SCS. b Ipsilateral PWT of SNL rats significantly increased after SCS without influencing contralateral PWT 
(n = 7). Saline (20 µL) was administered via the intrathecal catheters regardless of SCS. c The increase in ipsilateral PWT was completely reversed by 
intrathecal methysergide administration without influencing contralateral PWT (n = 6). d The increase in ipsilateral PWT was completely reversed 
by intrathecal idazoxan administration without influencing contralateral PWT (n = 6). Black square ipsilateral PWT with SCS, black diamond con-
tralateral PWT with SCS, gray circle ipsilateral PWT without SCS, gray triangle contralateral PWT without SCS. Data are mean ± SEM (g); *p < 0.05 and 
***p < 0.001 versus before SCS by one-way repeated-measures ANOVA followed by the Dunnett test.
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the ipsilateral-to-contralateral immunoreactivity ratio 
of DβH increased in the LC of SNL rats. SCS for 3  h 
returned the ratio to that seen in naïve rats (naïve, 
0.89 ± 0.03; SNL, 1.29 ± 0.09; SNL + SCS, 0.99 ± 0.06; 
p < 0.01; Figure 3t).
SCS did not increase the expression of TPH and DβH  
in the spinal dorsal horn
In all groups, no difference in enzymatic expression was 
noted between the ipsilateral and the contralateral sides 





















































































Figure 2 Double immunostaining of TPH and pCREB in representative DRN tissues. a–c Naïve rat; d–f SNL rat; and g–i SNL+SCS rat. The numbers 
of TPH-positive serotonergic neurons and pCREB-positive nuclei increased in the DRN region of the SNL+SCS rat compared with the SNL rat (scale 
bar = 20 μm). j Quantitative summary of pCREB-positive and TPH-positive serotonergic neurons in the DRN of the three groups. The numbers of 
both neuronal types in the DRN were significantly increased in SNL+SCS rats compared with SNL rats. k Quantitative summary of pCREB-positive 
serotonergic neurons among the total serotonergic neurons in the DRN. The percentage of pCREB-positive serotonergic neurons was significantly 
increased in SNL+SCS rats compared with SNL rats. Quantitative data were obtained from three consecutive slices of four rats per group. Data are 
mean ± SEM; *p < 0.05 and **p < 0.01 by the Tukey–Kramer test.
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pooled data from the ipsilateral and contralateral sides 
to the nerve injury relative to the average value of inter-
membrane controls. The TPH expression levels in SNL 
rats receiving SCS were significantly lower than those in 
SNL rats that did not receive SCS. The DβH expression 
levels were unaffected by SCS. (SNL, contralateral side: 
0.87 ± 0.09, ipsilateral side: 0.83 ± 0.09; SNL+SCS, con-
tralateral side: 0.66 ±  0.04, ipsilateral side: 0.62 ±  0.06, 
F [1, 47] = 8.16; p = 0.007), but did not affect the DβH 
expression levels (SNL, contralateral side: 0.78  ±  0.08, 
ipsilateral side: 0.74 ± 0.10; SNL+SCS, contralateral side: 
0.77 ± 0.10, ipsilateral side: 0.66 ± 0.08, F [1, 47] = 0.59; 
p = 0.44; Figure 4).
Discussion
In this study, we found that SCS increased the number of 
and activated serotonergic neurons in the DRN. It did not 
activate noradrenergic neurons in the LC but restored the 
ipsilateral-to-contralateral ratio of DβH expression in the 
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Figure 3 Double immunostaining of DβH and pCREB in representative bilateral LC tissues. a–c Naïve rat, contralateral side; j–l naïve rat, ipsilateral 
side; d–f SNL rat, contralateral side; m–o SNL rat, ipsilateral side; g–i SNL+SCS rat, contralateral side; p–r SNL+SCS rat, ipsilateral side. s Quantitative 
summary of pCREB-positive neurons in bilateral LC regions. No significant difference in the number of pCREB-positive neurons was noted among 
the groups. t Quantitative summary of the ipsilateral-to-contralateral ratio of pCREB-positive neurons and DβH immunoreactivity in bilateral LC 
regions. Quantitative data were obtained from three consecutive slices of four animals per group. Data are mean ± SEM; *p < 0.05 and **p < 0.01 by 
the Tukey–Kramer test.
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of SCS is mediated primarily by the serotonergic pathway 
supraspinal to the DAS and the noradrenergic pathway 
may have a smaller contribution, as recently suggested 
[29]. Moreover, the antinociceptive effect of SCS might 
not be mediated by local 5-HT and/or norepinephrine 
production, because TPH and DβH expression in the spi-
nal dorsal horn did not increase by SCS in SNL rats.
Supraspinal serotonergic contribution to SCS‑induced 
antinociception
A previous study showed that peripheral nerve injury 
reduces 5-HT content in the ipsilateral spinal dorsal 
horn and SCS increases this content in responsive rats 
[30]. Intrathecal administration of a subanalgesic dose 
of 5-HT elicits an antinociceptive response in animals 
not responsive to SCS [5]. Moreover, the antinociceptive 
effect of SCS is attenuated by 5-HT2A and 5-HT4 recep-
tor antagonists [31]. Accordingly, our behavioral study 
clearly showed serotonergic involvement in the antinoci-
ceptive effect of SCS.
Electrical stimulation of brain stem nuclei suppresses 
spinal nociceptive reflexes and attenuates nociceptive 
transmission by activating the serotonergic pathway 
of the DAS [6]. In this study, we found that 3-h SCS 
increased the numbers of TPH-expressing serotonergic 
neurons and pCREB-positive (activated) neurons, and 
the percentage of pCREB-positive serotonergic neurons 
in the DRN of injured rats. The DRN is located adjacent 
to the PAG and consists of dense serotonergic neuronal 
clusters, which project to the NRM at the RVM [32, 33]. 
The NRM is known to have crucial roles in the serotoner-
gic pathway of the DAS, because electrical stimulation of 
the RVM (NRM) enhances inhibitory synaptic transmis-
sion in the spinal dorsal horn [10] and induces antinocic-
eption [12]. Moreover, peripheral nerve injury attenuates 
the antinociceptive effect of morphine and induced neu-
ropathic pain behavior and decreases 5-HT concentra-
tion in the NRM [34]. A recent study has shown that “off 
cell”-like neurons in the RVM are suppressed in neu-
ropathic pain model rats, but SCS activates them and 
5-HT-like neurons only in responsive rats [35]. By this 
study, we firstly showed that serotonergic neurons in the 
DRN (those neurons projecting into the RVM) are acti-
vated by SCS. The DRN is thought to be a major 5-HT 
source in the CNS [36] and connects directly to the LC, 
providing a potent negative input [37]. Therefore, DRN 
activities in a neuropathic pain state may influence both 
the serotonergic and the noradrenergic pathways of the 
DAS.
Supraspinal noradrenergic contribution to SCS‑induced 
antinociception
The noradrenergic pathway of the DAS has been sug-
gested to be important for intrinsic antinociception 
in a neuropathic pain state and its facilitation may lead 
to anti-hyperalgesia, because noradrenergic neurons 
in the LC are activated in peripheral nerve-injured rats 
[13]. Furthermore, an α2-adrenergic agonist potentiates 
the antinociceptive effect of SCS [24]. By this study, we 
showed that the intrathecally administered α2-adrenergic 
receptor antagonist completely abolished the antino-
ciceptive effect of SCS. In addition, we found that the 
immunoreactivity of DβH in the ipsilateral LC of injured 
rats significantly increased but was restored by 3-h SCS, 
although the LC neurons were not activated by SCS 
in SNL rats. Similarly, unilateral nerve injury does not 
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Figure 4 Western blotting for TPH and DβH in the spinal dorsal horn 
with or without SCS. a Representative western blot of TPH and DβH 
from SNL rats with or without SCS. For the SNL+SCS group, the spinal 
cords were harvested after 3-h SCS. b Summary of the densitomet-
ric analysis of western blots of TPH and DβH (n = 6 in each group). 
“Ipsi” and “Contra” indicate the ipsilateral and the contralateral sides 
in SNL rats, respectively. No significant intragroup differences were 
noted. Data are the ratio of each intensity to the average intensity of 
intermembrane control and are shown as mean ± SEM; *p < 0.05 by 
unpaired t test.
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if innocuous mechanical stimuli are not applied [38]. 
Immunohistochemical changes in the LC region in neu-
ropathic animal models are controversial. Previous stud-
ies showed that unilateral nerve injury induces bilateral 
activation or excitability of LC neurons [13, 38, 39]; how-
ever, another study showed that DβH-positive neurons 
were increased in the LC on the ipsilateral side to sciatic 
nerve injury [14]. The LC receives only little input from 
fibers of the DRN, although noradrenergic neurons in 
the LC project to almost all the regions in the CNS [37]. 
Bilateral activation of noradrenergic neurons in the LC 
may be explained by projection from the DRN to both 
sides of the LC [37, 40]. We could not determine why 
the increase in DβH immunoreactivity was ipsilateral. 
However, the differences in the ratio of DβH expression 
in the LC among the three groups were relatively small 
and intrathecal administration of idazoxan without SCS 
did not alter ipsilateral PWT. The results of the behavio-
ral experiment agree with the evidence that chronic pain 
does not elicit tonic activity of LC neurons and secretion 
of norepinephrine in the spinal cord [38, 40, 41]. There-
fore, the expression change of DβH in the ipsilateral LC 
may only have a minor effect on the noradrenergic path-
way of the DAS. However, further research is needed to 
elucidate the roles of LC activation in the modulation of 
the noradrenergic antinociceptive pathway.
Recently, Song et  al. [29] have clearly shown that LC 
activation plays only a minor role in the antinociceptive 
effect of SCS, despite excitation of LC neurons in SCS-
responsive neuropathic pain model rats. Our results sim-
ilarly indicate that the noradrenergic pathway might play 
a secondary role.
Local 5‑HT and norepinephrine syntheses
The results of this study suggest that the antinocicep-
tive effect of SCS is mediated by both serotonergic and 
noradrenergic mechanisms in the spinal cord, but local 
synthesis of 5-HT and norepinephrine might not increase 
after SCS in the SNL rats. A previous study revealed 
bilateral increase in 5-HT immunoreactivity in the 
superficial dorsal horn after SCS, but the SCS-induced 
increase in the total 5-HT content was predominantly 
on the ipsilateral side to nerve injury [5]. Contrarily, 
the results of our western blot analyses showed that the 
expression level of TPH decreased after SCS in the spi-
nal dorsal horn of SNL rats. Sources of 5-HT in the spinal 
dorsal horn during SCS are supraspinal nuclei of sero-
tonergic neurons, as is the RVM [35]. Moreover, 5-HT 
production is absent in spinal cord segments below the 
site of total cord transection [26]. Taken together, these 
results strengthened the concept that the antinociceptive 
effect of SCS is achieved by supraspinal facilitation of the 
DAS [29, 35]. However, previous studies have also shown 
distinct segmental effects in antinociception by SCS in 
neuropathic pain model rats [27, 28], suggesting that 
both spinal and supraspinal mechanisms are involved in 
SCS-induced antinociception. Our study indicated that 
5-HT and norepinephrine might have smaller contribu-
tions in antinociceptive mechanisms in spinal cord seg-
ments. Segmental mechanisms of SCS antinociception 
are a recently proposed concept [27, 28]; further inves-
tigation is required to explain the complete mechanisms 
of antinociception by SCS. Controversially, both seroton-
ergic and noradrenergic mechanisms are reported to be 
involved in the pain-facilitatory pathways [38, 42–44]. 
Differences in receptor subunits and signal transduction 
may account for these reported discrepancies. Molecular 
mechanisms involved in serotonergic and noradrenergic 
pain modulation need to be investigated in detail.
Limitations
First, in this study, we used naïve animals and not sham-
operated animals. Unilateral nerve injury is known to 
affect contralateral PWT, because nerve injury may 
have bilateral effects. Therefore, the contralateral limb 
may not be comparable to a sham-operated limb or the 
limb of a naïve animal. In addition, hypersensitivity in 
one limb may artificially produce changes in the thresh-
old of the contralateral limb: if the animal cannot bear 
weight on the injured limb, it needs to put more weight 
on the contralateral limb. However, contralateral PWT 
was unchanged regardless of whether SCS significantly 
increased ipsilateral PWT or was not applied. Moreo-
ver, the behavioral experiment was aimed at determin-
ing serotonergic and noradrenergic contributions to 
the antinociceptive effect of SCS, not considering the 
ipsilateral-to-contralateral relationship in SCS-induced 
antinociception. Furthermore, sham operation may affect 
immunohistochemical and western blot observations 
because tissue damage may induce inflammation of the 
ipsilateral limb, which affects protein expression and glial 
cell activation in the spinal cord [45].
Second, we did not directly measure 5-HT and nor-
epinephrine contents by microdialysis or enzyme-linked 
immunosorbent assay. Previous studies already measured 
these contents in the spinal dorsal horn [29, 31]. Several 
studies revealed that however, no report has described 
the expression of the synthetic enzymes of 5-HT and 
norepinephrine in the spinal cord of unilaterally injured 
animals. Our findings strengthen the concept that SCS 
may activate the DAS, causing antinociception in the spi-
nal dorsal horn.
Conclusions
SCS-induced antinociception is mediated by both the 
serotonergic and the noradrenergic pathways of the DAS 
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in rats with unilateral spinal nerve injury. SCS causes 
histological changes in the DRN and LC, but it does not 
induce the expression of the synthetic enzymes of 5-HT 
and norepinephrine in the spinal dorsal horn of such 
animals. Therefore, the antinociceptive effect of SCS is 
mediated by activation of supraspinal centers of the DAS 




Male Sprague–Dawley rats weighing 350–400  g were 
used for the experiments. The animals were housed 
under a 12-h light/dark cycle in controlled temperature 
and humidity conditions and had free access to food and 
water. All experiments conformed to international guide-
lines on ethical use of animals [46], and all efforts were 
made to minimize pain and discomfort. Animal hous-
ing and surgical procedures were approved by the Insti-
tutional Animal Care and Use Committee of Yokohama 
City University Graduate School of Medicine (Approval 
No. F10-112). At the end of the experiments, all the ani-
mals were euthanized by an overdose of pentobarbital.
SNL and implantation procedures
The left L5 spinal nerve was ligated as previously 
described [47] with some modifications. In brief, animals 
were anesthetized with isoflurane (1.5–2%) in oxygen, 
and the left L6 transverse process was removed. The left 
L5 spinal nerve was identified and tightly ligated using a 
4-0 silk suture. The wound was then closed.
One week later, electrodes for SCS and intrathecal 
catheters were implanted as previously described [48]. In 
brief, animals anesthetized with isoflurane were placed 
in the supine position. After the back hair was clipped, 
a midline skin incision of 2–3 cm was made in the lum-
bar area (L2–5) and the vertebral muscles were bluntly 
dissected. Under binocular magnification, the L3 spinal 
process was removed, the L4 vertebra was retracted to 
expose the L2–3 and L3–4 intervertebral spaces, and the 
associated intervertebral ligaments were carefully cut. 
A silver electrode was inserted into the epidural space 
2–2.5  cm cephalad from the L2–3 intervertebral space 
such that its tip was located in the T11–13 area. Another 
silver electrode was inserted 1 cm caudally from the L3–4 
intervertebral space. These epidural electrodes (0.2  mm 
in diameter) were fabricated into ball-shaped tips and 
insulated by tubular polyethylene tubing (0.61  mm in 
outer diameter; PE-10, Becton, Dickinson and Company, 
Franklin Lakes. NJ).
At the same time, an intrathecal catheter (PE-10) was 
inserted in the same intervertebral space where the sil-
ver electrodes were inserted into the epidural space. The 
catheter was advanced 15 mm cephalad into the lumbar 
subarachnoid space so that its tip was located near the 
lumbar enlargement [49]. The electrodes and intrathecal 
catheter were then tunneled subcutaneously and exter-
nalized in the neck region. The volume of dead space of 
the intrathecal catheter was 15 μL.
Muscles, fascia, and skin were closed with 3-0 silk 
sutures in layers. The animals were typically allowed to 
recover for a minimum of 5  days before testing. Those 
showing signs of motor weakness or paresis after recov-
ery from anesthesia were euthanized. By histopathologi-
cal analysis of a harvested spinal cord, we confirmed that 
the electrode tips were placed on the dorsal spinal sur-
face at the T10–11 level and left side of the same surface 
at the L4–5 level.
Behavioral analysis
The behavioral assessments were performed under 
standardized conditions in a separate quiet room. On 
each testing day, rats were brought into the quiet room 
1  h before the test session to allow them to habituate 
to the environment. Mechanical hypersensitivity was 
assessed with a Dynamic Plantar Aesthesiometer (Ugo 
Basile, Comerio, Italy), which is an automated von Frey 
device [50–52].
To measure hind-paw mechanical thresholds, animals 
were placed in plastic cages with a wire mesh floor and 
allowed to acclimate for 15 min before each test session. 
A paw-flick response was elicited by applying an increas-
ing force using a plastic filament (0.5 mm in diameter) on 
the center of the plantar surface of both hind paws. The 
force applied was initially below the detection threshold, 
then increased from 1 to 50 g in 1 g increments over 20 s, 
and finally held at 50 g for 10 s. The rate of increase was 
2.5  g/s. PWT was defined as the force applied to elicit 
reflex removal of the hind paw. The mean of five meas-
urements at 1-min intervals was calculated to determine 
PWT of each side.
Spinal cord stimulation (SCS)
After the baseline PWT measurement, the implanted 
electrodes were connected to an electrical stimulator 
(SEN-3301, Nihon Kohden, Tokyo, Japan) via an isola-
tor (SS-201J, Nihon Kohden) with wire leads, allowing 
the animals to move freely in the cage. Monopolar elec-
trical stimuli with a frequency of 50 Hz and pulse width 
of 0.2  ms were applied. The amplitude was individually 
determined as 70–80% of the intensity required to pro-
duce slight twitching in the lower trunk muscles or leg 
stretching (i.e., motor threshold), as reported in previous 
studies [24, 48]. We defined a response as increased PWT 
(>130% of the initial value) on the ipsilateral side after 
1-h SCS.
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Intrathecal drug administration
We used rats showing attenuation of mechanical hyper-
sensitivity after 1-h SCS for the subsequent experiments. 
After obtaining the 1-h PWT measurement, we admin-
istered 30  μg of methysergide maleate (5-HT1- and 
5-HT2-receptor antagonist), idazoxan hydrochloride (α2-
adrenergic receptor antagonist), or saline via the intrath-
ecal catheter (total volume =  10  μL) using a Hamilton 
syringe, followed by 10 μL of saline to rinse the catheter. 
PWT was remeasured at 1 and 2 h after drug administra-
tion (Figure 1). Unstimulated SNL animals served as pos-
itive controls. The drugs were dissolved in saline and kept 
at −80°C before use. Their doses were determined from a 
previous report [53].
Immunohistochemistry
Animals showing increased PWT after 3-h SCS, unstim-
ulated SNL animals, and naïve rats (negative controls) 
(n  =  4 rats per group) were deeply anesthetized with 
sodium pentobarbital (50 mg/kg) and perfused intracar-
dially with heparinized phosphate-buffered saline (PBS), 
followed by 4% cold buffered paraformaldehyde with 2% 
saturated picric acid solution. The brains were rapidly 
removed, fixed in the same fixative solution at 4°C over-
night, and cryoprotected in 30% sucrose solution at 4°C 
until they completely sank. The medullae, containing 
the DRN (bregma 7.30–7.80  mm [54]) and LC (bregma 
9.68–10.04 mm [54]), were sliced in 20-µm sections and 
mounted on Frontier-coated glass slides (Matsunami 
Glass, Osaka, Japan). Then, sections were incubated over-
night in a mixture of primary antibodies: sheep anti-TPH 
(1:400; Sigma-Aldrich, St. Louis, MO) and rabbit anti-
serine 133 pCREB (1:1,000; Upstate, EMD Millipore, 
Billerica, MA) for DRN-containing slices or mouse anti-
DβH (1:400; EMD Millipore) and anti-pCREB (1:1,000; 
Upstate, EMD Millipore, Billerica, MA) for LC-contain-
ing slices. The following secondary antibodies were used: 
donkey anti-sheep immunoglobulin G coupled to fluo-
rescein isothiocyanate (FITC) for TPH (1:400), donkey 
anti-mouse coupled to DyLight 488 for DβH (1:400), and 
donkey anti-rabbit coupled to DyLight 549 for pCREB 
(1:400) (Jackson ImmunoResearch, West Grove, PA).
Immunofluorescent reactions were observed under an 
all-in-one epifluorescence microscope (Biorevo BZ-9000, 
Keyence Corporation, Osaka, Japan) equipped with exci-
tation filters for tetramethylrhodamine (TRITC) and 
FITC fluorescence wavelengths. Images of DRN- and LC-
containing slices, identified by TPH- and DβH-positive 
neuronal clusters, respectively, were captured using a 
digital camera containing a charge-coupled device and 
connected to the epifluorescence microscope system. 
Two to three sections were chosen from within 80  µm 
of the rostral-to-caudal extents of the DRN and LC per 
rat for analysis with ImageJ software (National Institutes 
of Health, Bethesda, MA) after binarization. TRITC-
stained ovoid particles were considered as pCREB-posi-
tive nuclei. All FITC-stained cell bodies, with or without 
stained nuclei, were considered as TPH-positive neu-
rons. The percentage of pCREB-positive serotonergic 
neurons was calculated from the total number of TPH-
positive neurons counted visually. Further, the average 
fluorescence intensity (arbitrary units from 0 to 255 per 
pixel) of DβH-positive neurons and number of pCREB-
positive nuclei were quantified in the chosen LC sections. 
The ipsilateral-to-contralateral immunoreactivity ratio 
of DβH was then calculated. The immunohistochemical 
analyses were performed by two researchers (KS and AY) 
in a blinded manner.
Western blot analysis
Animals showing increased PWT after 3-h SCS (n = 6), 
unstimulated SNL animals (n = 6) were deeply anesthe-
tized with sodium pentobarbital (50  mg/kg) and per-
fused intracardially with heparinized cold PBS. The L4–5 
segment of the spinal cord was rapidly removed and 
divided into quarters (left dorsal, left ventral, right dor-
sal, and right ventral). The dorsal quarters were immedi-
ately but separately frozen in liquid nitrogen and stored 
at −80°C until use. Frozen samples were homogenized 
with ice-cold solubilizing buffer (10-mM hydroxyethyl 
piperazineethanesulfonic acid, 1.0-mM ethylenediamine-
tetraacetic acid, 2.0-mM ethylene glycol tetraacetic acid, 
0.5-mM dithiothreitol, 0.1-mMphenylmethanesulfonyl 
fluoride, 10-mg/L leupeptin, and 100-nM microcystin) 
and sonicated and boiled at 97°C for 5 min.
Protein concentration was determined by using a 
BCA reagent assay kit (Pierce, Thermo Fisher Scientific, 
Rockford, IL). Protein samples (10  μg/well for the dor-
sal quarters, 5  μg/well for each brain) were subjected 
to 8% polyacrylamide gel electrophoresis in the pres-
ence of sodium dodecyl sulfate and transferred electro-
phoretically to polyvinylidene difluoride membranes. 
The membranes were incubated in a blocking solution, 
5% skim milk dissolved in Tris-buffered saline contain-
ing 0.1% Tween-20 (pH 7.4), for 1  h at room tempera-
ture. They were then incubated with anti-TPH antibody 
(1:2,000; Sigma-Aldrich), anti-DβH antibody (1:1,000; 
Cell Signaling Technology, Danvers, MA), and anti-β-
actin monoclonal antibody (1:20,000, Sigma-Aldrich) 
overnight in the blocking solution at 4°C. Subsequently, 
they were washed with Tris-buffered saline containing 
0.1% Tween-20 and incubated in donkey anti-rabbit and 
sheep anti-mouse horseradish peroxidase (both 1:20,000; 
GE Healthcare, Piscataway, NJ) in the blocking solu-
tion for 1 h at room temperature. Immunodetection was 
performed with ECL Advance reagents (GE Healthcare) 
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according to the manufacturer’s instructions and quan-
tified by densitometry using LAS3000 and Multi Gauge 
software (Fujifilm, Tokyo, Japan). For each band, blank 
values were first subtracted. Variations between gels were 
controlled by expressing the results as a ratio to the inter-
membrane control. Data were calculated as ratios of each 
intensity to the average value of intermembrane control.
Statistical analysis
Behavioral data are shown as means (g) ± standard error 
of the mean (SEM). Immunohistochemical data are 
shown as mean ± SEM of actual cell counts in the DRN 
or ipsilateral-to-contralateral ratio of DβH optical density 
in the LC. Western blot data are shown as mean ± SEM 
of relative optical density. Two-way repeated-measures 
analysis of variance (ANOVA) was used to analyze the 
effects of SCS and the drugs on PWT in each group; then, 
one-way repeated-measures ANOVA followed by the 
Dunnett test were used for intergroup behavioral com-
parisons. Immunohistochemical data were compared 
among the groups by one-way ANOVA followed by the 
Tukey–Kramer test. Western blot data between SNL and 
SNL+SCS groups were compared by two-way repeated-
measures ANOVA followed by unpaired t tests. Values 
of p less than 0.05 were considered significant. The data 
were analyzed using the XLSTAT Microsoft Excel macro 
(ver. 2015. 2.01.16567, Addinsoft, New York, NY).
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